摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-benzyl hydrogen 2-oxoglutarate | 108050-01-7

中文名称
——
中文别名
——
英文名称
1-benzyl hydrogen 2-oxoglutarate
英文别名
1-benzyl α-ketoglutarate;benzyl 2-oxoglutarate;2-oxo-pentanedioic acid 1-benzyl ester;1-benzyl 2-oxoglutarate;4,5-dioxo-5-phenylmethoxypentanoic acid
1-benzyl hydrogen 2-oxoglutarate化学式
CAS
108050-01-7
化学式
C12H12O5
mdl
——
分子量
236.224
InChiKey
GZPGJPVRPLMKFS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    51-52 °C
  • 沸点:
    423.7±38.0 °C(Predicted)
  • 密度:
    1.287±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    17
  • 可旋转键数:
    7
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    80.7
  • 氢给体数:
    1
  • 氢受体数:
    5

反应信息

点击查看最新优质反应信息

文献信息

  • Cyclic hydroxamates, especially multiply substituted [1,2]oxazinan-3-ones
    作者:Saul Wolfe、Marie-Claire Wilson、Ming-Huei Cheng、Gennady V Shustov、Christiana I Akuche
    DOI:10.1139/v03-122
    日期:2003.8.1

    Routes to putative N-acyl-D-ala-D-ala surrogates, beginning with the conversion of 4-, 5-, and 6-membered lactones into 5-, 6-, and 7-membered cyclic hydroxamates, are reported. The key step of the synthesis is trimethylaluminium-promoted cyclization of an ω-aminooxyester. The 7-membered cyclic hydroxamate crystallizes in a chair conformation. Extension of the reaction sequence to homoserine or homoserine lactone leads to cyclocanaline and N-acylated cyclocanalines. The 4-phenylacetamido derivative of cyclocanaline crystallizes in a boat conformation. The attachment of a 2-carboxypropyl substituent to the ring nitrogen of a 4-acylaminocyclocanaline has been effected, prior to cyclization, by coupling of the acyclic aminooxyester precursor to the triflate of benzyl lactate or, after cyclization, by coupling to tert-butyl α-bromopropionate in the presence of potassium fluoride – alumina, followed by removal of the protecting group in each case. A six-membered homolog of the antibiotic lactivicin has been synthesized by the reaction of 4-phenylacetamidocyclocanaline with benzyl 2-oxoglutarate in the presence of carbodiimide, followed by hydrogenolysis. Starting with methyl 2,4-dibromo-2,4-dideoxy-L-erythronate, which is available in two steps from L-ascorbic acid, these reaction sequences have been applied to the stereospecific synthesis of a D-alanine derivative whose nitrogen atom is enclosed within a 3,4-disubstituted [1,2]oxazinan-3-one. Key words: D-ala-D-ala surrogate, cyclocanaline, homolactivicin, peptidoglycan, trimethylaluminium.

    报道了将假定的N-酰-D-阿拉-D-阿拉替代物的合成途径,从将4、5和6元环内酯转化为5、6和7元环氢氧化物开始。合成的关键步骤是ω-氧酯的三甲基铝促进的环化反应。7元环氢氧化物以椅式构象结晶。将反应序列扩展到同型丝氨酸或同型丝氨酸内酯会导致环康纳林和N-酰化环康纳林的形成。环康纳林的4-苯乙酰基衍生物以船式构象结晶。在环康纳林的4-酰基环康纳林的环氮上附加2-羧基丙基取代基,可以通过将无环氧酯前体与苄乳酸三甲酯三氟甲磺酸酯偶联,或在环化之后,通过与三甲基丙酸叔丁酯-氧化铝存在下偶联,然后在每种情况下去除保护基来实现。通过4-苯乙酰基环康纳林与苄基2-氧戊二酸酯在异亚胺存在下反应,然后进行氢解,合成了抗生素拉维西汀的六元同系物。从甲基2,4-二-2,4-二去氧-L-赤葡萄糖酸甲酯开始,该物质可以从抗坏血酸中经过两步合成,这些反应序列已被应用于立体特异性合成一种D-丙氨酸生物,其氮原子被包含在一个3,4-二取代[1,2]噁唑烷-3-酮内。关键词:D-ala-D-ala替代物,环康纳林,同型拉维西汀,肽聚糖,三甲基铝
  • [EN] TREATMENT OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS AND COMPOUNDS FOR SAME<br/>[FR] TRAITEMENT DE TROUBLES ASSOCIÉS AU STRESS OXYDATIF ET COMPOSÉS CORRESPONDANTS
    申请人:UNIV ADELAIDE
    公开号:WO2021179049A1
    公开(公告)日:2021-09-16
    The present invention relates to the treatment of disorders associated with oxidative stress including neuropathic pain and small synthetically derived compounds for treating such disorders.
    本发明涉及治疗与氧化应激相关的疾病,包括神经性疼痛以及用于治疗这些疾病的小型合成化合物。
  • Tricyclic cepham compounds
    申请人:Takeda Chemical Industries, Ltd.
    公开号:US04891427A1
    公开(公告)日:1990-01-02
    The compounds having a 4,11-dioxo-3-oxa-8(or 7)-thia-1-azatricyclo[7,2,0,0.sup.2,6 ]undecane-2-carboxylic acid skeleton as the base structure, their esters and their salts are useful antibacterial agents.
    这些具有4,11-二氧-3-氧-8(或7)--1-氮杂七环[7,2,0,0.sup.2,6]十一烷-2-羧酸骨架作为基本结构的化合物,它们的酯和盐是有用的抗菌剂。
  • Total Synthesis of the Siderophore Vibrioferrin.
    作者:Yasuo TAKEUCHI、Teruaki AKIYAMA、Takashi HARAYAMA
    DOI:10.1248/cpb.47.459
    日期:——
    Total synthesis of vibrioferrin (1), a siderophore, was achieved via chiral dibenzyl citrate separated by optical resolution. It was elucidated that the configuration of the citrate moiety of vibrioferrin was R.
    通过光学拆分获得的手性二苯基柠檬酸酯,实现了载体维里素(1)的全合成。研究发现,维里素中柠檬酸部分的构型为R型。
  • Gamma-lactonecarboxylic acid derivatives and their use as antibacterial
    申请人:Takeda Chemical Industries, Ltd.
    公开号:US04882434A1
    公开(公告)日:1989-11-21
    A compound represented by formula (I): ##STR1## wherein R.sup.1 is an organic residue through a carbon atom, R.sup.2 is a carboxyl group which may be esterified or amidated, and X is an oxygen atom, or a sulfur atom which may be oxidized, or a salt thereof, which is useful as antibacterial agent or intermediate for synthesizing the same, and a process for preparing the same.
    一种由化学式(I)表示的化合物:##STR1## 其中R.sup.1是通过碳原子连接的有机残基,R.sup.2是一个可以酯化或酰胺化的羧基,X是一个氧原子,或者一个可以氧化的原子,或其盐,用作抗菌剂或用于合成相同的中间体,以及制备该化合物的方法。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫